SARS-CoV-2 Omicron variant
Type of coronavirus detected in 2021
GlyphSignal keeps some article pages out of search while editorial context is expanded.
Why this is trending
Interest in “SARS-CoV-2 Omicron variant” spiked on Wikipedia on 2026-07-21.
Categorised under Science & Nature, this article fits a familiar pattern. Interest in science articles on Wikipedia often follows major discoveries, published studies, or tech industry news.
By monitoring millions of daily Wikipedia page views, GlyphSignal helps you spot cultural moments as they happen and understand the stories behind the numbers.
Key Takeaways
- 529) is a heavily mutated variant of SARS-CoV-2 first reported to the World Health Organization (WHO) by the Network for Genomics Surveillance in South Africa on 24 November 2021.
- Following the original B.
- Two subvariants of BA.
- In mid-2023, the extremely-mutated BA.
- Its main descendent, JN.
Source note: This page combines GlyphSignal analysis with attributed reference material from Wikipedia. GlyphSignal adds trend context, traffic history, categorization, and editorial interpretation. See how we build these pages.
Source summary
WikipediaOmicron (B.1.1.529) is a heavily mutated variant of SARS-CoV-2 first reported to the World Health Organization (WHO) by the Network for Genomics Surveillance in South Africa on 24 November 2021. It was first detected in Botswana and has spread to become the predominant variant in circulation around the world. Following the original B.1.1.529 variant, several subvariants of Omicron have emerged, including: BA.1, BA.2, BA.3, BA.4, and BA.5. Two subvariants of BA.5 emerged by October 2022, called BQ.1 and BQ.1.1.
In mid-2023, the extremely-mutated BA.2.86 variant emerged. Its main descendent, JN.1 (BA.2.86.1.1), emerged soon afterward and swept the globe that winter, becoming dominant within a few months. Since then, all circulating lineages have descended from JN.1. JN.1 went on to spawn multiple notable sublineages, including KP.3.1.1 and XEC in 2024, and LP.8.1, NB.1.8.1, and XFG in 2025. XFG became the dominant variant globally over the summer of 2025.
Three doses of a COVID-19 vaccine provide protection against severe disease and hospitalization caused by Omicron and its subvariants. For three-dose vaccinated individuals, the BA.4 and BA.5 variants are more infectious than previous subvariants but there is no evidence of greater sickness or severity.
Content sourced from Wikipedia under CC BY-SA 4.0
